504 related articles for article (PubMed ID: 36683709)
1. Emerging roles of non-coding RNAs in colorectal cancer oxaliplatin resistance and liquid biopsy potential.
Luo ZD; Wang YF; Zhao YX; Yu LC; Li T; Fan YJ; Zeng SJ; Zhang YL; Zhang Y; Zhang X
World J Gastroenterol; 2023 Jan; 29(1):1-18. PubMed ID: 36683709
[TBL] [Abstract][Full Text] [Related]
2. Competitive endogenous RNA networks: Decoding the role of long non-coding RNAs and circular RNAs in colorectal cancer chemoresistance.
Khalafizadeh A; Hashemizadegan SD; Shokri F; Bakhshinejad B; Jabbari K; Motavaf M; Babashah S
J Cell Mol Med; 2024 Apr; 28(7):e18197. PubMed ID: 38506091
[TBL] [Abstract][Full Text] [Related]
3. The emerging role of noncoding RNAs in colorectal cancer chemoresistance.
Wei L; Wang X; Lv L; Zheng Y; Zhang N; Yang M
Cell Oncol (Dordr); 2019 Dec; 42(6):757-768. PubMed ID: 31359293
[TBL] [Abstract][Full Text] [Related]
4. Involvement of Non-coding RNAs in the Signaling Pathways of Colorectal Cancer.
Yang Y; Du Y; Liu X; Cho WC
Adv Exp Med Biol; 2016; 937():19-51. PubMed ID: 27573893
[TBL] [Abstract][Full Text] [Related]
5. N6-methyladenosine RNA modification and its interaction with regulatory non-coding RNAs in colorectal cancer.
Ge Y; Liu T; Wang C; Zhang Y; Xu S; Ren Y; Feng Y; Yin L; Pu Y; Liang G
RNA Biol; 2021 Nov; 18(sup2):551-561. PubMed ID: 34674600
[TBL] [Abstract][Full Text] [Related]
6. Deciphering the functional landscape and therapeutic implications of noncoding RNAs in the TGF-β signaling pathway in colorectal cancer: A comprehensive review.
Saadh MJ; Allela OQB; Sattay ZJ; Al Zuhairi RAH; Ahmad H; Eldesoky GE; Adil M; Ali MS
Pathol Res Pract; 2024 Mar; 255():155158. PubMed ID: 38320438
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNAs: Key regulators in oxaliplatin resistance of colorectal cancer.
Qi FF; Yang Y; Zhang H; Chen H
Biomed Pharmacother; 2020 Aug; 128():110329. PubMed ID: 32502843
[TBL] [Abstract][Full Text] [Related]
8. Non-coding RNAs as Biomarkers for Survival in Colorectal Cancer Patients.
Andrabi MQ; Kesavan Y; Ramalingam S
Curr Aging Sci; 2024; 17(1):5-15. PubMed ID: 36733201
[TBL] [Abstract][Full Text] [Related]
9. Non-coding RNAS and colorectal cancer liver metastasis.
Zhou XY; Luo B; Jiang ZK; Xie YK; Wu FC; Huang JQ; Chen JS
Mol Cell Biochem; 2020 Dec; 475(1-2):151-159. PubMed ID: 32767228
[TBL] [Abstract][Full Text] [Related]
10. Role of Non-Coding RNAs in Colorectal Cancer: Focus on Long Non-Coding RNAs.
Lulli M; Napoli C; Landini I; Mini E; Lapucci A
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362222
[TBL] [Abstract][Full Text] [Related]
11. LncRNA CACS15 contributes to oxaliplatin resistance in colorectal cancer by positively regulating ABCC1 through sponging miR-145.
Gao R; Fang C; Xu J; Tan H; Li P; Ma L
Arch Biochem Biophys; 2019 Mar; 663():183-191. PubMed ID: 30639170
[TBL] [Abstract][Full Text] [Related]
12. Regulatory Roles of Non-Coding RNAs in Colorectal Cancer.
Wang J; Song YX; Ma B; Wang JJ; Sun JX; Chen XW; Zhao JH; Yang YC; Wang ZN
Int J Mol Sci; 2015 Aug; 16(8):19886-919. PubMed ID: 26307974
[TBL] [Abstract][Full Text] [Related]
13. The Role of Exosomal Non-Coding RNAs in Colorectal Cancer Drug Resistance.
Lampropoulou DI; Pliakou E; Aravantinos G; Filippou D; Gazouli M
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163397
[TBL] [Abstract][Full Text] [Related]
14. CAF-derived exosomal lncRNA FAL1 promotes chemoresistance to oxaliplatin by regulating autophagy in colorectal cancer.
Zhu S; Mao J; Zhang X; Wang P; Zhou Y; Tong J; Peng H; Yang B; Fu Q
Dig Liver Dis; 2024 Feb; 56(2):330-342. PubMed ID: 37400281
[TBL] [Abstract][Full Text] [Related]
15. Role of non-coding RNAs as new therapeutic targets in regulating the EMT and apoptosis in metastatic gastric and colorectal cancers.
Ebrahimi N; Hakimzadeh A; Bozorgmand F; Speed S; Manavi MS; Khorram R; Farahani K; Rezaei-Tazangi F; Mansouri A; Hamblin MR; Aref AR
Cell Cycle; 2023 Oct; 22(20):2302-2323. PubMed ID: 38009668
[TBL] [Abstract][Full Text] [Related]
16. Non-coding RNAs Enabling Prognostic Stratification and Prediction of Therapeutic Response in Colorectal Cancer Patients.
Perakis SO; Thomas JE; Pichler M
Adv Exp Med Biol; 2016; 937():183-204. PubMed ID: 27573901
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of MEG3 sensitizes colorectal cancer cells to oxaliplatin through regulation of miR-141/PDCD4 axis.
Wang H; Li H; Zhang L; Yang D
Biomed Pharmacother; 2018 Oct; 106():1607-1615. PubMed ID: 30119236
[TBL] [Abstract][Full Text] [Related]
18. Noncoding RNAs in inflammation and colorectal cancer.
Ma S; Long T; Huang WJM
RNA Biol; 2020 Nov; 17(11):1628-1635. PubMed ID: 31847691
[TBL] [Abstract][Full Text] [Related]
19. IRF-1 mediated long non-coding RNA PVT1-214 promotes oxaliplatin resistance of colorectal cancer via miR-128 inhibition.
Tong D; Zou E; Bai L; Ma J; Guo N; Wang H; Jiang L
J BUON; 2020; 25(5):2205-2214. PubMed ID: 33277837
[TBL] [Abstract][Full Text] [Related]
20. Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer.
Liu T; Zhang X; Du L; Wang Y; Liu X; Tian H; Wang L; Li P; Zhao Y; Duan W; Xie Y; Sun Z; Wang C
Mol Cancer; 2019 Mar; 18(1):43. PubMed ID: 30890168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
